Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8Prostatic Neoplasms 5Polycystic Ovary Syndrome 5Multiple Myeloma 5Colorectal Neoplasms 5Small Cell Lung Carcinoma 4Rectal Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Stomach Neoplasms 2Pancreatic Neoplasms 2Fibrosis 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Hepatocellular 2Breast Carcinoma In Situ 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Venous Thromboembolism 1Urinary Bladder Neoplasms 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Thrombosis 1Sprains and Strains 1Smoldering Multiple Myeloma 1Sepsis 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma 1

Interventions

Simvastatin 1Danazol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Long Qt Syndrome 3 × Simvastatin × Clear all
NCT00575601 2009-07-02

Effects of Simvastatin on Biochemical Parameters and Outcome of IVF-ICSI in Pcos Patients

Tehran University of Medical Sciences

Phase 3 Completed
120 enrolled

Long Qt Syndrome 3, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡